What is Core Biogenesis?
Core Biogenesis is at the forefront of biodesign, specializing in regenerative medicine and longevity skincare solutions. The company innovates by utilizing plants as sophisticated biofactories to produce high-value recombinant proteins. These proteins are targeted for the Life Science and Beauty & Wellness sectors, with a proprietary platform technology designed to enhance protein stability by directing them to plant oleosomes. This approach to bioproduction not only addresses market needs but also champions a more sustainable future.
How much funding has Core Biogenesis raised?
Core Biogenesis has raised a total of $10.5M across 1 funding round:
Series A
$10.5M
Series A (2022): $10.5M with participation from Blue Horizon Ventures, XAnge, and Thia Ventures
Key Investors in Core Biogenesis
Blue Horizon Ventures
Blue Horizon Ventures is a venture capital fund focused on sustainable food systems and plant-based proteins, likely providing strategic guidance and capital to advance Core Biogenesis's bioproduction technologies.
XAnge
XAnge is a European early-stage venture capital firm with extensive experience in supporting startups from Seed to Series B, suggesting they offer both capital and operational expertise to help Core Biogenesis scale its innovative biodesign platform.
Thia Ventures
Thia Ventures invests at the intersection of food, biotechnology, and health, indicating a strategic interest in Core Biogenesis's application of plant-based technology for regenerative medicine and skincare markets.
What's next for Core Biogenesis?
With its recent major strategic investment, Core Biogenesis is poised for significant scaling and further development of its unique bioproduction platform. The company's focus on regenerative medicine and longevity skincare, coupled with its sustainable plant-based protein technology, positions it for substantial growth within the Life Science and Beauty & Wellness industries. Future endeavors will likely involve expanding production capabilities, forging new strategic partnerships, and advancing its product pipeline to capitalize on the increasing demand for innovative and sustainable solutions.
See full Core Biogenesis company page
